IG
IGX.F Ingevity Corporation
- Market cap
- EUR 1.87B
- P/E
- 61.7x
- P/B
- 31.44x
- ROE
- 305.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is IGX.F undervalued?
Graham numberThe Graham number of Ingevity Corporation cannot be estimated reliably (the estimate is too far from the market price).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Ingevity Corporation fundamental analysis
No fundamental analysis for Ingevity Corporation yet.
Ingevity Corporation stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Ingevity Corporation
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline va…
Full company profileIngevity Corporation financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Ingevity Corporation annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 908M | 972M | 1.13B | 1.29B | 1.22B | 1.39B | 1.67B | 1.22B | 1.20B | 1.17B | 1.17B |
| Gross Profit | 274M | 329M | 417M | 482M | 466M | 513M | 570M | 445M | 465M | 462M | 518M |
| Operating Income | 160M | 203M | 263M | 299M | 294M | 307M | 341M | 258M | 283M | 262M | 332M |
| EBITDA | - | 233M | 312M | 368M | 382M | 320M | 433M | 346M | 64.4M | 41.4M | 350M |
| Net Income | 35.2M | 127M | 169M | 184M | 186M | 118M | 212M | -5.40M | -430M | -167M | 193M |
| EPS | - | 3.01 | 4.06 | 4.39 | 4.60 | 3.01 | 5.67 | -0.15 | -12 | -4.71 | 5.67 |
| Balance Sheet | |||||||||||
| Total Assets | 833M | 930M | 1.32B | 2.14B | 2.33B | 2.47B | 2.74B | 2.62B | 2.02B | 1.65B | 1.50B |
| Total Liabilities | 698M | 652M | 977M | 1.61B | 1.69B | 1.80B | 2.04B | 1.99B | 1.83B | 1.62B | 1.44B |
| Shareholders' Equity | 127M | 264M | 339M | 531M | 647M | 674M | 698M | 631M | 195M | 29.7M | 63.0M |
| Cash & Short-term Investments | 30.5M | 87.9M | 77.5M | 56.5M | 258M | 275M | 76.7M | 95.9M | 68.0M | 78.1M | 85.4M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 128M | 174M | 252M | 276M | 352M | 293M | 313M | 259M | 129M | 331M | 111M |
| Capital Expenditure | 56.7M | 52.6M | 93.9M | 115M | 82.1M | 104M | 143M | 130M | 77.6M | 57.7M | 45.7M |
| Free Cash Flow | - | 122M | 158M | 161M | 247M | 189M | 171M | 129M | 51.0M | 274M | 65.5M |
| Ratios | |||||||||||
| ROE | 27.7% | 47.9% | 49.9% | 34.6% | 28.8% | 17.5% | 30.3% | -0.9% | -220.4% | -562.6% | 305.6% |
| ROA | 4.2% | 13.6% | 12.9% | 8.6% | 8.0% | 4.8% | 7.7% | -0.2% | -21.3% | -10.1% | 12.8% |
| Net Profit Margin | 3.9% | 13.0% | 14.9% | 14.2% | 15.3% | 8.5% | 12.7% | -0.4% | -35.9% | -14.3% | 16.5% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Ingevity Corporation dividends
Ingevity Corporation has not paid dividends in the last 9 fiscal years.
Who owns Ingevity Corporation
- Insiders 0.79%
- Institutions 99.21%
- Public & others 0.00%
- Shares outstanding 33.8M
- Free float 33.5M
Ingevity Corporation company profile
- Company name
- Ingevity Corporation
- Ticker
- IGX.F
- Exchange
- Frankfurt Exchange
- Sector
- Basic Materials
- Industry
- Chemicals
- Employees
- 1,400
- Fiscal year end
- December
- Address
- 4920 O'Hear Avenue, North Charleston, SC, United States, 29405
- Phone
- 843 740 2300
- Website
- ingevity.com
About Ingevity Corporation
Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products for use in gasoline vapor emission control systems in cars, trucks, motorcycles, and boats. This segment also produces other activated carbon products for food, water, beverage, and chemical purification applications. The Performance Chemicals segment consists of road technologies and industrial specialties. This segment's products are used in pavement construction, pavement preservation, pavement reconstruction and recycling, road markings, agrochemical dispersants, lubricants, certain adhesives, rubber, and other industrial uses. The Advanced Polymer Technologies segment produces caprolactone and caprolactone-based specialty polymers for use in coatings, resins, elastomers, adhesives, bioplastics, and medical devices. It serves automotive parts manufacturers through sales representatives, third-party sales representatives, and distributors. The company was formerly known as WestRock Company, Specialty Chemicals Business and changed its name to Ingevity Corporation in September 2015. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.
Ingevity Corporation management
10- Mr. David H. LiPresident, CEO & Director · born 1973
- Mr. Ryan C. FisherSenior VP, General Counsel & Secretary · born 1976
- Mr. Terrance M. DyerSenior VP & Chief Human Resources Officer · born 1967
- Mr. Phillip John PlattSenior VP & CFO · born 1981
- Mr. Reid ClontzSenior Vice President of Operations · born 1974
- Mr. Ryan CottermanVice President, Chief Accounting Officer & Principal Accounting Officer · born 1982
- Mr. Michael H. WalshVice President of Investor Relations
- Ms. Caroline MonahanDirector of Communications
- Mr. Michael N. ShukovSenior VP & President of Advanced Polymer Technologies · born 1969
- Ms. Ruth CastilloSenior VP & President of Performance Materials · born 1978